Cargando…

Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19

The dysfunctional effects of the coronavirus disease 2019 (COVID-19) infection on the nervous system are established. The manifestation of neuropsychiatric symptoms during and after infection is influenced by the neuroinvasive and neurotrophic properties of SARS-CoV-2 as well as strong inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dąbrowska, Eliza, Galińska-Skok, Beata, Waszkiewicz, Napoleon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541562/ https://www.ncbi.nlm.nih.gov/pubmed/34685427 http://dx.doi.org/10.3390/life11101056

Ejemplares similares

The Effect of Antidepressant Treatment on Neurocognitive Functions, Redox and Inflammatory Parameters in the Context of COVID-19
por: Samaryn, Eliza, et al.
Publicado: (2023)

Markers of Schizophrenia—A Critical Narrative Update
por: Galińska-Skok, Beata, et al.
Publicado: (2022)

Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia
por: Szulc, Agata, et al.
Publicado: (2012)

Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients
por: Galińska-Skok, Beata, et al.
Publicado: (2019)

Neurobiological Effects of Binge Drinking Help in Its Detection and Differential Diagnosis from Alcohol Dependence
por: Waszkiewicz, Napoleon, et al.
Publicado: (2018)

Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study
por: Galińska-Skok, Beata, et al.
Publicado: (2018)

Clozapine treatment during the COVID-19 pandemic
por: Dąbrowska, E., et al.
Publicado: (2021)

Increased Depression and Anxiety Disorders during the COVID-19 Pandemic in Children and Adolescents: A Literature Review
por: Śniadach, Justyna, et al.
Publicado: (2021)

Biomarkers of Post-COVID Depression
por: Lorkiewicz, Piotr, et al.
Publicado: (2021)

Salivary Carbohydrate-Deficient Transferrin in Alcohol- and Nicotine-Dependent Males
por: Waszkiewicz, Napoleon, et al.
Publicado: (2020)

The Impact of the COVID-19 Virus Pandemic on the Incidence of First Psychotic Spectrum Disorders
por: Łoś, Kacper, et al.
Publicado: (2022)

Peripheral Markers of Depression
por: Nobis, Aleksander, et al.
Publicado: (2020)

Biological Markers in Anxiety Disorders
por: Łoś, Kacper, et al.
Publicado: (2021)

Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?—A Narrative Review
por: Lorkiewicz, Piotr, et al.
Publicado: (2022)

The Immunoseasonal Theory of Psychiatric Disorders
por: Waszkiewicz, Napoleon
Publicado: (2023)

Ordering Knowledge in the Markers of Psychiatric/Mental Disorders
por: Waszkiewicz, Napoleon
Publicado: (2022)

Mentally Sick or Not—(Bio)Markers of Psychiatric Disorders Needed
por: Waszkiewicz, Napoleon
Publicado: (2020)

Urine 3-Nitrotyrosine and Serum HDL as Potential Biomarkers of Depression
por: Nobis, Aleksander, et al.
Publicado: (2023)

Biomarkers of Postpartum Depression: A Narrative Review
por: Modzelewski, Stefan, et al.
Publicado: (2023)

Salivary Biomarkers of Stress, Anxiety and Depression
por: Chojnowska, Sylwia, et al.
Publicado: (2021)

Risk Assessment of Depression amongst Women during Menopause before and during the COVID-19 Pandemic
por: Kułak-Bejda, Agnieszka, et al.
Publicado: (2022)

Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
por: Wilczyńska, Karolina, et al.
Publicado: (2020)

Old and New Biomarkers of Alcohol Abuse: Narrative Review
por: Fakhari, Sara, et al.
Publicado: (2023)

Diagnostic Value of Salivary Markers in Neuropsychiatric Disorders
por: Kułak-Bejda, Agnieszka, et al.
Publicado: (2019)

First-Time Psychotic Symptoms in a Patient After COVID-19 Infection—A Case Report
por: Łoś, Kacper, et al.
Publicado: (2021)

Positive Correlation of Serum N-Acetyl-β-hexosaminidase with Markers of Atherosclerosis in Diabetes Type 2 Patients with Mild Symptoms of Depression and Anxiety
por: Chojnowska, Sylwia, et al.
Publicado: (2018)

Relapsing-Remitting Severe Bickerstaff’s Brainstem Encephalitis – Case Report and Literature Review
por: Tyrakowska, Zuzanna, et al.
Publicado: (2016)

Mental Disorders, Cognitive Impairment and the Risk of Suicide in Older Adults
por: Kułak-Bejda, Agnieszka, et al.
Publicado: (2021)

The use of light, temperature and pressure in the treatment of depression
por: Zalewski, D., et al.
Publicado: (2021)

Biochemical markers of depression - an up-to-date review
por: Nobis, A., et al.
Publicado: (2021)

E‐cigarette or vaping product‐use‐associated lung injury partly due to the new‐psychoactive‐substances
por: Waszkiewicz, Napoleon
Publicado: (2020)

Potential Role of L-Carnitine in Autism Spectrum Disorder
por: Kępka, Alina, et al.
Publicado: (2021)

Editorial: Neurocognitive disorders and depression—Complex interrelationships
por: Broczek, Katarzyna Milana, et al.
Publicado: (2023)

The Influence of Covid-19 Infection on Neurocognitive Disorders
por: GLĂVAN, DANIELA GABRIELA, et al.
Publicado: (2021)

COVID-19, neurocognitive disorders, and civil capacity
por: Valença, Alexandre M., et al.
Publicado: (2020)

Can the practice of mindfulness reduce medical errors?
por: Łoś, Kacper, et al.
Publicado: (2022)

Postoperative neurocognitive disorders
por: Tasbihgou, Setayesh Reza, et al.
Publicado: (2021)

HIV Associated Neurocognitive Disorders
por: Zhou, Li, et al.
Publicado: (2013)

HIV-associated neurocognitive disorders
por: Sanmarti, Montserrat, et al.
Publicado: (2014)

Intergenerational Perioperative Neurocognitive Disorder
por: Ju, Ling-Sha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u389i3eatgbqsj1sh7ue52sclp